MENU

REPL Replimune Group Forecast, Technical & Fundamental Analysis

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies... Show more

Industry: #Biotechnology
REPL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
REPL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

REPL is expected to report earnings to fall 11.03% to -67 cents per share on October 29

Replimune Group REPL Stock Earnings Reports
Q3'26
Est.
$-0.68
Q1'26
Missed
by $0.07
Q4'25
Missed
by $0.01
Q3'25
Missed
by $0.13
Q2'25
Missed
by $0.11
The last earnings report on June 29 showed earnings per share of -75 cents, missing the estimate of -68 cents. With 4.55M shares outstanding, the current market capitalization sits at 1.15B.
A.I. Advisor
published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
500 Unicorn Park Drive
Phone
+1 781 222-9600
Employees
479
Web
https://www.replimune.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JHDRX21.74N/A
N/A
JPMorgan Hedged Equity 2 R6
DHLTX27.47N/A
N/A
Diamond Hill Select I
BVAOX10.97N/A
N/A
Madison Small Cap Y
FMFMX18.12N/A
N/A
Fidelity Advisor Series Equity Gr
RFNEX104.26-0.23
-0.22%
American Funds Fundamental Invs R-4

REPL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with IMNN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then IMNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REPL
1D Price
Change %
REPL100%
+13.35%
IMNN - REPL
57%
Loosely correlated
+1.24%
SNDX - REPL
49%
Loosely correlated
-0.15%
KYMR - REPL
45%
Loosely correlated
+0.99%
NRIX - REPL
43%
Loosely correlated
+1.37%
ZYME - REPL
42%
Loosely correlated
+2.63%
More
Replimune Group (REPL) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com